Technologies and implementations for a wearable medical device (WMD). The technologies and implementations facilitate improved comfort and usability of WMDs. Additionally, the technologies and implementations include WMDs having wearable cardioverter defibrillator capabilities.

An external defibrillator system is provided. The system includes: a graphical display; one or more sensors for obtaining data regarding chest compressions performed on a patient; and a controller configured to display on the graphical display numeric values for depth and/or rate of the chest compressions based upon the data from the one or more sensors. A method for using an external defibrillator including the steps of: obtaining data regarding chest compressions performed on a patient; and displaying on a graphical display screen of the defibrillator numeric values for depth and/or rate of the chest compressions based upon the data is also provided.

A system to deliver therapeutic energy to a patient, the system including a storage capacitor configured to store and release the therapeutic energy, a boost converter circuit coupled to the storage capacitor, and a current flow control circuit coupled to the boost converter circuit and including a plurality of control circuits configured to control a current output from the current flow control circuit in a therapeutic biphasic voltage waveform upon release of the therapeutic energy from the storage capacitor, wherein the therapeutic biphasic voltage waveform includes a ramped increase in voltage from approximately zero volts to a desired therapeutic voltage level over a time interval greater than 1 millisecond and less than a time associated with a phase switch.

A chemical etch is performed on a sheet of material. An electrochemical etch is performed on the sheet of material after the chemical etch is performed on the sheet of material. A capacitor is fabricated such that an electrode included in the capacitor includes material from the sheet of material after the electrochemical etch was performed on the sheet of material. In some instances, the chemical etch included at least partially immersing the sheet of material in an etch bath that includes molybdenum. Additionally or alternately, the chemical etch can be performed for a period of time less than 60 s.

Provided are a defibrillation catheter system, a defibrillation power supply device, and a method for controlling the device during observation of intracardiac potential and defibrillation. A defibrillation catheter system 1 includes a catheter 20; a power supply part 6 connected to the catheter 20; an electrocardiograph 40 measuring an intracardiac potential; a first electrode 21 and a second electrode 22 provided on the catheter; and a changeover part 7 connected to the power supply part 6, the changeover part 7 switching between a first mode for measuring the intracardiac potential and a second mode for applying the voltage while the intracardiac potential is measured, wherein the first electrode 21 and the second electrode 22 are connected to the power supply part 6 through the changeover part 7, and the first electrode 21 and the second electrode 22 are connected to the electrocardiograph 40.

A wet electrolytic capacitor that contains a cathode, fluidic working electrolyte, and anode that includes a sintered porous pellet is provided. A dielectric layer is also formed on a surface of the pellet and within its pores through anodic oxidation. The present inventors have discovered that through selective control over the anodic oxidation process, a substantially amorphous, low crystalline dielectric layer can be formed which, among other things, exhibits a leakage current that is smaller than previously thought possible for the high voltage capacitors employed in implantable medical devices.

Systems and methods related to the field of cardiac resuscitation, and in particular to devices for assisting rescuers in performing cardio-pulmonary resuscitation (CPR).

A patient-worn arrhythmia monitoring and treatment device includes a pair of therapy electrodes and at least one pair of sensing electrodes disposed proximate to the skin and configured to continually sense at least one ECG signal of the patient over an extended period of time. The device includes a therapy delivery circuit coupled to the pair of therapy electrodes and configured to deliver one or more therapeutic pulses. A controller coupled to therapy delivery circuit is configured to analyze the at least one ECG signal and detect one or more treatable arrhythmias and cause the therapy delivery circuit to deliver the one or more therapeutic pulses to the patient. At least one of the one or more therapeutic pulses is formed as a biphasic waveform delivering within 15 percent of 360 J of energy to a patient body having a transthoracic impedance from about 20 to about 200 ohms.

In an example, an implantable medical device (IMD) includes a hold capacitor configured to deliver an electrical therapy pulse, and charge pump circuitry configured to transfer energy from the battery to the hold capacitor. In this example, the charge pump circuitry comprises a plurality of capacitors, and switching circuitry configured to put the charge pump circuitry into a K-factor mode selected from a group of K-factor modes by opening and closing a combination of switches connected to the plurality of capacitors.

A medical device that includes a power source, a therapy delivery interface, therapy electrodes, electrocardiogram (ECG) sensing electrodes to sense ECG signal of a heart of a patient, a sensor interface to receive and digitize the ECG signal, and a processor. The processor is configured to analyze the ECG signal to determine a cardiac rhythm and a transform value representing a magnitude of a frequency component of the cardiac rhythm, analyze the cardiac rhythm and the transform value to detect a shockable cardiac arrhythmia by classifying the cardiac rhythm as a noise rhythm or a shockable cardiac arrhythmia rhythm based on the transform value, and causing the processor to detect the cardiac arrhythmia if classifying the cardiac rhythm as a shockable cardiac arrhythmia rhythm, initiate a treatment alarm sequence, adjust the shock delivery parameter for a defibrillation shock, and provide the defibrillation shock via the therapy electrodes.